Browsing by Subject Vacunes

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 99  next >
Issue DateTitleAuthor(s)
24-Mar-2020A micro-elimination approach to addressing hepatitis C in TurkeyIdilman, Ramazan; Razavi, Homie; Robbins-Scott, Sarah; Akarca, Ulus Salih; Örmeci, Necati; Kaymakoglu, Sabahattin; Aygen, Bilgehan; Tozun, Nurdan; Güner, Rahmet; Hurrem; Lazarus, Jeffrey V.
4-Feb-2017A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patientsRello, Jordi; Krenn, Claus-Georg; Locker, Gottfried; Pilger, Ernst; Madl, Christian; Balica, Laura; Dugernier, Thierry; Laterre, Pierre-François; Spapen, Herbert; Depuydt, Pieter; Vincent, Jean-Louis; Bogár, Lajos; Szabó, Zsuzsanna; Vólgyes, Barbara; Máñez Mendiluce, Rafael; Cakar, Nahit; Ramazanoglu, Atilla; Topeli, Arzu; Mastruzzo, Maria A.; Jasovich, Abel; Remolif, Christian G.; Soria, Liliana del Carmen; Andersen Hernandez, Max A.; Ruiz Balart, Carolina; Krémer, Ildikó; Molnár, Zsolt; Sonnenburg, Frank von; Lyons, Arthur; Joannidis, Michael; Burgmann, Heinz; Welte, Tobias; Klingler, Anton; Hochreiter, Romana; Westritschnig, Kerstin
1-Jun-2021Activation of interferon regulatory factor 3 by replication-competent Vaccinia viruses improves antitumor efficacy mediated by T-cell responsesRiederer, Stephanie; Fux, Robert; Lehmann, Michael H.; Volz, Asisa; Sutter, Gerd; Rojas, Juan J.
21-Apr-2022Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal studySelma-Royo, Marta; Bäuerl, Christine; Mena-Tudela, Desirée; Aguilar-Camprubí, Laia; Pérez-Cano, Francisco J.; Parra-Llorca, Anna; Lerin, Carles; Martínez Costa, Cecilia; Collado, Maria Carmen
17-Jun-2022Antibody signatures in Plasmodium falciparum and helminth infections: immune deviation, serological diagnosis and vaccine responsesSantano García, Rebeca
Aug-2014Awareness of Meningococcal disease among travelers from the United Kingdom to the meningitis belt in AfricaGoodman, Anna L.; Masuet Aumatell, Cristina; Halbert, Jay; Zuckerman, Jane N.
18-Jul-2022BA.5 Omicron subvariant in Catalonia: Current impact and recommendations for booster vaccination strategiesMultidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC); Blanco Arbués, Julià; Sarukhan, Adelaida; Díez Antón, Juana, 1962-; Bassat Orellana, Quique; Campins Martí, Magda; Güerri Fernández, Robert; Brotons, Carlos; Sans Corrales, Mireia; Miró Meda, José M.; Sanjosé Llongueras, Silvia de
20-Apr-2023Cellular senescence and adaptive immune responsesMarin Guillen, Ines
1985Cent anys de la primera vacuna anticolèricaParés i Farràs, Ramon, 1927-2018
13-Jul-2009Clinical development of RTS,S as a vaccine for the prevention of malaria in Mozambican childrenSacarlal, Jahit
4-Jul-2022Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variantsMonteil, Vanessa; Eaton, Brett; Postnikova, Elena; Murphy, Michael; Braunsfeld, Benedict; Crozier, Ian; Kricek, Franz; Niederhofer, Janine; Schwarzbock, Alice; Breid, Helene; Devignot, Stephanie; Klingstrom, Jonas; Thalin, Charlotte; Kellner, Max J; Christ, Wanda; Havervall, Sebastian; Mereiter, Stefan; Knapp, Sylvia; Sanchez Jimenez, Anna; Bugajska-Schretter, Agnes; Dohnal, Alexander; Ruf, Christine; Gugenberger, Romana; Hagelkruys, Astrid; Montserrat, Nuria; Kozieradzki, Ivona; Ali, Omar Hasan; Stadlmann, Johannes; Holbrook, Michael R; Schmaljohn, Connie; Oostenbrink, Chris; Shoemaker, Robert H; Mirazimi, Ali; Wirnsberger, Gerald; Penninger, Josef M
10-Feb-2021Codon Usage and Adenovirus Fitness: Implications for Vaccine DevelopmentGiménez Roig, Judit; Nuñez Manchón, Estela; Alemany Bonastre, Ramon; Villanueva, Eneko; Fillat i Fonts, Cristina
20-Jun-2023Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune NeurologyDalakas, Marinos C.; Dalmau Obrador, Josep
8-Feb-2020Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacyVélez, Rita; Gállego Culleré, M. (Montserrat)
1-Jun-2023Computational Prediction of Trypanosoma cruzi Epitopes Toward the Generation of an Epitope-Based Vaccine Against Chagas DiseaseRos Lucas, Albert; Rioja Soto, David; Gascon, Joaquim; Alonso Padilla, Julio
2012Concepcions errònies de les vacunesAguilar Palma, Elisabet; Célard, Noémie; Enjuanes Brualla, Montse; Genís Pujols, Núria
23-Nov-2020COVID-19 Immunisation Strategy: Priority PopulationsMultidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC); Sanjosé Llongueras, Silvia de; Miró Meda, José M.; Bassat Orellana, Quique; Campins Martí, Magda; Güerri Fernández, Robert; Brotons, Carlos; Díez Antón, Juana, 1962-; Blanco Arbués, Julià; Sans Corrales, Mireia; Rubio, Olga; Sarukhan, Adelaida
13-Feb-2022Covid-19: ¿Por qué son necesarias las dosis de refuerzo?Domínguez García, Àngela
6-Apr-2017Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in SpainCàmara, Jordi; Marimón, José María; Cercenado, Emilia; Larrosa, Nieves; Quesada, María Dolores; Fontanals, Dionísia; Cubero, Meritxell; Pérez Trallero, Emilio; Fenoll, Asunción; Liñares Louzao, Josefina; Ardanuy Tisaire, María Carmen
6-Apr-2022Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination.Hernández Luis, Pablo; Aguilar, Ruth; Pelegrin Pérez, Judit; Ruiz Olalla, Gemma; García-Basteiro, Alberto L.; Tortajada, Marta; Moncunill, Gemma; Dobaño, Carlota, 1969; Angulo Aguado, Ana; Engel Rocamora, Pablo